Imaging Patterns Characterizing Mitochondrial Leukodystrophies

References

1. 1.↵
   1. van der Knaap MS,
   2. Schiffmann R,
   3. Mochel F, et al

   . Diagnosis, prognosis, and treatment of leukodystrophies. Lancet Neurol 2019;18:962–72 doi:10.1016/S1474-4422(19)30143-7 pmid:31307818

   CrossRefPubMedGoogle Scholar
2. 2.↵
   1. Köhler W,
   2. Curiel J,
   3. Vanderver A

   . Adulthood leukodystrophies. Nat Rev Neurol 2018;14:94–105 doi:10.1038/nrneurol.2017.175 pmid:29302065

   CrossRefPubMedGoogle Scholar
3. 3.↵
   1. Stellitano LA,
   2. Winstone AM,
   3. van der Knaap MS, et al

   . Leukodystrophies and genetic leukoencephalopathies in childhood. Dev Med Child Neurol 2016;58:680–89 doi:10.1111/dmcn.13027 pmid:26866636

   CrossRefPubMedGoogle Scholar
4. 4.↵
   1. Bonkowsky JL,
   2. Nelson C,
   3. Kingston JL, et al

   . The burden of inherited leukodystrophies in children. Neurology 2010;75:718–25 doi:10.1212/WNL.0b013e3181eee46b pmid:20660364

   CrossRefPubMedGoogle Scholar
5. 5.↵
   1. Area-Gomez E,
   2. Schon EA

   . Mitochondrial genetics and disease. J Child Neurol 2014;29:1208–15 doi:10.1177/0883073814539561 pmid:25028417

   CrossRefPubMedGoogle Scholar
6. 6.↵
   1. Baertling F,
   2. Klee D,
   3. Haack TB, et al

   . The many faces of paediatric mitochondrial disease on neuroimaging. Childs Nerv Syst 2016;32:2077–83 doi:10.1007/s00381-016-3190-3 pmid:27449766

   CrossRefPubMedGoogle Scholar
7. 7.↵
   1. Morató L,
   2. Bertini E,
   3. Verrigni D, et al

   . Mitochondrial dysfunction in CNS white matter disorders. Glia 2014;62:1878–94 doi:10.1002/glia.22670 pmid:24865954

   CrossRefPubMedGoogle Scholar
8. 8.↵
   1. Chu BC,
   2. Terae S,
   3. Takahashi C, et al

   . MRI of the brain in Kearns-Sayre syndrome. Neuroradiology 1999;41:759–64 doi:10.1007/s002340050838 pmid:10552027

   CrossRefPubMedWeb of ScienceGoogle Scholar
9. 9.↵
   1. Millar WS,
   2. Lignelli A,
   3. Hirano M

   . MRI of five patients with mitochondrial neurogastrointestinal encephalomyopathy. AJR Am J Roentgenol 2004;182:1537–41 doi:10.2214/ajr.182.6.1821537 pmid:15150004

   CrossRefPubMedGoogle Scholar
10. 10.↵
    1. Kevelam S,
    2. Steenweg M,
    3. Srivastava S, et al

    . Update on leukodystrophies: historical perspective and adapted definition. Neuropediatrics 2016;47:349–54 doi:10.1055/s-0036-1588020 pmid:27564080

    CrossRefPubMedGoogle Scholar
11. 11.↵
    1. Kevelam SH,
    2. Rodenburg RJ,
    3. Wolf NI, et al

    . NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern. Neurology 2013;80:1577–83 doi:10.1212/WNL.0b013e31828f1914 pmid:23553477

    Abstract/FREE Full TextGoogle Scholar
12. 12.↵
    1. Melchionda L,
    2. Haack TB,
    3. Hardy S, et al

    . Mutations in APOPT1, encoding a mitochondrial protein, cause cavitating leukoencephalopathy with cytochrome c oxidase deficiency. Am J Hum Genet 2014;95:315–25 doi:10.1016/j.ajhg.2014.08.003 pmid:25175347

    CrossRefPubMedGoogle Scholar
13. 13.↵
    1. Theunissen TE,
    2. Szklarczyk R,
    3. Gerards M, et al

    . Specific MRI abnormalities reveal severe Perrault syndrome due to CLPP defects. Front Neurol 2016;7:203 doi:10.3389/fneur.2016.00203 pmid:27899912

    CrossRefPubMedGoogle Scholar
14. 14.↵
    1. Dallabona C,
    2. Abbink TE,
    3. Carrozzo R, et al

    . LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. Brain 2016;139:782–94 doi:10.1093/brain/awv392 pmid:26912632

    CrossRefPubMedGoogle Scholar
15. 15.↵
    1. van Berge L,
    2. Hamilton EM,
    3. Linnankivi T, et al

    . LBSL Research Group. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation. Brain 2014;137:1019–29 doi:10.1093/brain/awu026 pmid:24566671

    CrossRefPubMedWeb of ScienceGoogle Scholar
16. 16.↵
    1. van der Knaap MS,
    2. Bugiani M,
    3. Mendes MI, et al

    . Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. Neurology 2019;92:e1225–37 doi:10.1212/WNL.0000000000007098 pmid:30737337

    Abstract/FREE Full TextGoogle Scholar
17. 17.↵
    1. Steenweg ME,
    2. Ghezzi D,
    3. Haack T, et al

    . Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 2012;135:1387–94 doi:10.1093/brain/aws070 pmid:22492562

    CrossRefPubMedWeb of ScienceGoogle Scholar
18. 18.↵
    1. Dallabona C,
    2. Diodato D,
    3. Kevelam SH, et al

    . Novel (ovario)leukodystrophy related to AARS2 mutations. Neurology 2014;82:2063–71 doi:10.1212/WNL.0000000000000497 pmid:24808023

    Abstract/FREE Full TextGoogle Scholar
19. 19.↵
    1. Helman G,
    2. Caldovic L,
    3. Whitehead MT, et al

    . SDH Study Group. MRI spectrum of succinate dehydrogenase-related infantile leukoencephalopathy. Ann Neurol 2016;79:379–86 doi:10.1002/ana.24572 pmid:26642834

    CrossRefPubMedGoogle Scholar
20. 20.↵
    1. Torraco A,
    2. Ardissone A,
    3. Invernizzi F, et al

    . Novel mutations in IBA57 are associated with leukodystrophy and variable clinical phenotypes. J Neurol 2017;264:102–11 doi:10.1007/s00415-016-8312-z pmid:27785568

    CrossRefPubMedGoogle Scholar
21. 21.↵
    1. Gurgel-Giannetti J,
    2. Lynch DS,
    3. Paiva A. D, et al

    . Novel complex neurological phenotype due to a homozygous mutation in FDX2. Brain 2018;141:2289–98 doi:10.1093/brain/awy172 pmid:30010796

    CrossRefPubMedGoogle Scholar
22. 22.↵
    1. van der Knaap MS,
    2. Breiter SN,
    3. Naidu S, et al

    . Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999;213:121–33 doi:10.1148/radiology.213.1.r99se01121 pmid:10540652

    CrossRefPubMedWeb of ScienceGoogle Scholar
23. 23.↵
    1. van der Knaap MS,
    2. Valk J

    . Magnetic Resonance of Myelination and Myelin Disorders. Springer-Verlag; 2005

    Google Scholar
24. 24.↵
    1. van der Lei H,
    2. Steenweg M,
    3. Barkhof F, et al

    . Characteristics of early MRI in vanishing white matter. Neuropediatrics 2012;43:22–26 doi:10.1055/s-0032-1307456 pmid:22430157

    CrossRefPubMedGoogle Scholar
25. 25.↵
    1. Bourekas EC,
    2. Varakis K,
    3. Bruns D, et al

    . Lesions of the corpus callosum: MRI and differential considerations in adults and children. AJR Am J Roentgenol 2002;179:251–57 doi:10.2214/ajr.179.1.1790251 pmid:12076946

    CrossRefPubMedWeb of ScienceGoogle Scholar
26. 26.↵
    1. Drenckhahn A,
    2. Schuelke M,
    3. Knierim E

    . Leukodystrophy with multiple beaded periventricular cysts in Canavan disease. J Inherit Metab Dis 2015;38:983–84 doi:10.1007/s10545-015-9812-1 pmid:25647544

    CrossRefPubMedGoogle Scholar
27. 27.↵
    1. Ulrick N,
    2. Goldstein A,
    3. Simons C, et al

    . RMND1-related leukoencephalopathy with temporal lobe cysts and hearing loss. Pediatr Neurol 2017;66:59–62 doi:10.1016/j.pediatrneurol.2016.09.003 pmid:27843092

    CrossRefPubMedGoogle Scholar
28. 28.↵
    1. Trocello JM,
    2. Woimant F,
    3. El Balkhi S, et al

    . Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease. Neurology 2013;81:1557–57 doi:10.1212/WNL.0b013e3182a95883 pmid:24145882

    Abstract/FREE Full TextGoogle Scholar
29. 29.↵
    1. Kruer MC,
    2. Boddaert N,
    3. Schneider A, et al

    . Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012;33:407–14 doi:10.3174/ajnr.A2677 pmid:21920862

    Abstract/FREE Full TextGoogle Scholar
30. 30.↵
    1. Hitoshi S,
    2. Iwata M,
    3. Yoshikawa K

    . Mid-brain pathology of Wilson’s disease. J Neurol Neurosurg Psychiatry 1991;54:624–26 doi:10.1136/jnnp.54.7.624 pmid:1895127

    Abstract/FREE Full TextGoogle Scholar
31. 31.↵
    1. Mochel F,
    2. Schiffmann R,
    3. Steenweg ME, et al

    . Adult polyglucosan body disease: natural history and key MRI findings. Ann Neurol 2012;72:433–41 doi:10.1002/ana.23598 pmid:23034915

    CrossRefPubMedGoogle Scholar
32. 32.↵
    1. Melberg A,
    2. Hallberg L,
    3. Kalimo H, et al

    . MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol 2006;27:904–11 pmid:16611789

    Abstract/FREE Full TextGoogle Scholar
33. 33.↵
    1. Okamoto K,
    2. Tokiguchi S,
    3. Furusawa T, et al

    . MR features of diseases involving bilateral middle cerebellar peduncles. AJNR Am J Neuroradiol 2003;24:1946–54 pmid:14625215

    Abstract/FREE Full TextGoogle Scholar
34. 34.↵
    1. Shrivastava A

    . The hot cross bun sign. Radiology 2007;245:606–07 doi:10.1148/radiol.2452041856 pmid:17940314

    CrossRefPubMedGoogle Scholar
35. 35.↵
    1. Tan AP,
    2. Robles C,
    3. Mankad K

    . Cerebellar atrophy with T2/FLAIR hyperintense cerebellar cortex. Childs Nerv Syst 2018;34:601–03 doi:10.1007/s00381-018-3762-5 pmid:29488078

    CrossRefPubMedGoogle Scholar
36. 36.↵
    1. Poretti A,
    2. Wolf N,
    3. Boltshauser E

    . Differential diagnosis of cerebellar atrophy in childhood: an update. Neuropediatrics 2015;46:359–70 doi:10.1055/s-0035-1564620 pmid:26444039

    CrossRefPubMedGoogle Scholar